
### [NCIT:C7481](http://purl.obolibrary.org/obo/NCIT_C7481)
**Label:** Malignant Gallbladder Neoplasm

**Subclasses:** [NCIT:C134675](http://purl.obolibrary.org/obo/NCIT_C134675) (Stage IV Gallbladder Cancer AJCC v8), [NCIT:C4439](http://purl.obolibrary.org/obo/NCIT_C4439) (Stage 0 Gallbladder Cancer AJCC v6 and v7), [NCIT:C134672](http://purl.obolibrary.org/obo/NCIT_C134672) (Stage III Gallbladder Cancer AJCC v8), [NCIT:C5840](http://purl.obolibrary.org/obo/NCIT_C5840) (Gallbladder Angiosarcoma), [NCIT:C5841](http://purl.obolibrary.org/obo/NCIT_C5841) (Gallbladder Leiomyosarcoma), [NCIT:C5842](http://purl.obolibrary.org/obo/NCIT_C5842) (Gallbladder Kaposi Sarcoma), [NCIT:C9167](http://purl.obolibrary.org/obo/NCIT_C9167) (Undifferentiated Gallbladder Carcinoma), [NCIT:C9166](http://purl.obolibrary.org/obo/NCIT_C9166) (Gallbladder Adenocarcinoma), [NCIT:C90216](http://purl.obolibrary.org/obo/NCIT_C90216) (Stage I Gallbladder Cancer AJCC v7), [NCIT:C96919](http://purl.obolibrary.org/obo/NCIT_C96919) (Gallbladder Neuroendocrine Carcinoma), [NCIT:C9170](http://purl.obolibrary.org/obo/NCIT_C9170) (Gallbladder Squamous Cell Carcinoma), [NCIT:C35676](http://purl.obolibrary.org/obo/NCIT_C35676) (Localized Malignant Gallbladder Neoplasm), [NCIT:C90218](http://purl.obolibrary.org/obo/NCIT_C90218) (Stage III Gallbladder Cancer AJCC v7), [NCIT:C91229](http://purl.obolibrary.org/obo/NCIT_C91229) (Gallbladder Cancer by AJCC v7 Stage), [NCIT:C90217](http://purl.obolibrary.org/obo/NCIT_C90217) (Stage II Gallbladder Cancer AJCC v7), [NCIT:C96915](http://purl.obolibrary.org/obo/NCIT_C96915) (Gallbladder Adenocarcinoma, Biliary Type), [NCIT:C90219](http://purl.obolibrary.org/obo/NCIT_C90219) (Stage IV Gallbladder Cancer AJCC v7), [NCIT:C5734](http://purl.obolibrary.org/obo/NCIT_C5734) (Gallbladder Lymphoma), [NCIT:C5735](http://purl.obolibrary.org/obo/NCIT_C5735) (Gallbladder Melanoma), [NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma), [NCIT:C134663](http://purl.obolibrary.org/obo/NCIT_C134663) (Stage 0 Gallbladder Cancer AJCC v8), [NCIT:C5736](http://purl.obolibrary.org/obo/NCIT_C5736) (Gallbladder Sarcoma), [NCIT:C5737](http://purl.obolibrary.org/obo/NCIT_C5737) (Stage I Gallbladder Cancer AJCC v6), [NCIT:C134667](http://purl.obolibrary.org/obo/NCIT_C134667) (Stage II Gallbladder Cancer AJCC v8), [NCIT:C134665](http://purl.obolibrary.org/obo/NCIT_C134665) (Stage I Gallbladder Cancer AJCC v8), [NCIT:C7356](http://purl.obolibrary.org/obo/NCIT_C7356) (Gallbladder Adenosquamous Carcinoma), [NCIT:C134660](http://purl.obolibrary.org/obo/NCIT_C134660) (Gallbladder Cancer by AJCC v8 Stage), [NCIT:C96927](http://purl.obolibrary.org/obo/NCIT_C96927) (Gallbladder Mixed Adenoneuroendocrine Carcinoma), [NCIT:C96928](http://purl.obolibrary.org/obo/NCIT_C96928) (Gallbladder Goblet Cell Carcinoid), [NCIT:C96887](http://purl.obolibrary.org/obo/NCIT_C96887) (Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma), [NCIT:C96888](http://purl.obolibrary.org/obo/NCIT_C96888) (Gallbladder Carcinosarcoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C5738](http://purl.obolibrary.org/obo/NCIT_C5738) (Stage II Gallbladder Cancer AJCC v6), [NCIT:C5739](http://purl.obolibrary.org/obo/NCIT_C5739) (Stage III Gallbladder Cancer AJCC v6), [NCIT:C5745](http://purl.obolibrary.org/obo/NCIT_C5745) (Gallbladder Signet Ring Cell Carcinoma), [NCIT:C7649](http://purl.obolibrary.org/obo/NCIT_C7649) (Localized Gallbladder Carcinoma), [NCIT:C96890](http://purl.obolibrary.org/obo/NCIT_C96890) (Gallbladder Hepatoid Adenocarcinoma), [NCIT:C3844](http://purl.obolibrary.org/obo/NCIT_C3844) (Gallbladder Carcinoma), [NCIT:C96891](http://purl.obolibrary.org/obo/NCIT_C96891) (Gallbladder Cribriform Carcinoma), [NCIT:C5743](http://purl.obolibrary.org/obo/NCIT_C5743) (Gallbladder Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C5744](http://purl.obolibrary.org/obo/NCIT_C5744) (Gallbladder Mucinous Adenocarcinoma), [NCIT:C5740](http://purl.obolibrary.org/obo/NCIT_C5740) (Stage IV Gallbladder Cancer AJCC v6), [NCIT:C7482](http://purl.obolibrary.org/obo/NCIT_C7482) (Metastatic Malignant Neoplasm in the Gallbladder), [NCIT:C43604](http://purl.obolibrary.org/obo/NCIT_C43604) (Gallbladder Adenocarcinoma, Intestinal-Type), [NCIT:C90512](http://purl.obolibrary.org/obo/NCIT_C90512) (Gallbladder Cancer by AJCC v6 Stage), [NCIT:C43605](http://purl.obolibrary.org/obo/NCIT_C43605) (Gallbladder Clear Cell Adenocarcinoma), [NCIT:C6763](http://purl.obolibrary.org/obo/NCIT_C6763) (Gallbladder Small Cell Neuroendocrine Carcinoma), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), [NCIT:C5839](http://purl.obolibrary.org/obo/NCIT_C5839) (Gallbladder Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002110](http://purl.obolibrary.org/obo/UBERON_0002110) (gall bladder) 62.50%
- [UBERON:0017672](http://purl.obolibrary.org/obo/UBERON_0017672) (abdominal viscera) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0013765](http://purl.obolibrary.org/obo/UBERON_0013765) (digestive system element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0005173](http://purl.obolibrary.org/obo/UBERON_0005173) (abdominal segment element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0005172](http://purl.obolibrary.org/obo/UBERON_0005172) (abdomen element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0013765](http://purl.obolibrary.org/obo/UBERON_0013765) (digestive system element) and [UBERON:0017672](http://purl.obolibrary.org/obo/UBERON_0017672) (abdominal viscera) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0017672](http://purl.obolibrary.org/obo/UBERON_0017672) (abdominal viscera) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) and [UBERON:0013765](http://purl.obolibrary.org/obo/UBERON_0013765) (digestive system element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) and [UBERON:0005173](http://purl.obolibrary.org/obo/UBERON_0005173) (abdominal segment element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) and [UBERON:0005172](http://purl.obolibrary.org/obo/UBERON_0005172) (abdomen element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) and [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 62.50%
- Thing 51.60%
- [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 47.86%
- [UBERON:0005177](http://purl.obolibrary.org/obo/UBERON_0005177) (trunk region element) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 47.86%


